The Pulse Podcast

The Pulse Podcast takes a deep dive into biotech stories, features key biotech figures, and inspires the next generation of biotech leaders. The Pulse is presented by the Harvard Biotech Club. hbcpulse.substack.com

The Pulse Podcast is a technology podcast hosted by Unknown Host, with 16 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts The Pulse Podcast, a technology show with 16 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  The Pulse Podcast

  Chuan He: Philosophies on the Wall Between Academia and Industry

  May 27, 202641 minS0

  <p>Chuan He is a world-renowned epigeneticist, a Wolf Prize laureate, and a recent inductee of the National Academy of Sciences. Chuan’s lab at the University of Chicago has spun out numerous companies including Ellis Bio (DNA methylation detection technologies) and Aferna Bio (plant biology). His discovery of the first RNA demethylase introduced a new layer of transcriptional regulation, and his subsequent work resulted in epigenetic based tools for detecting biomarkers of cancer, created super-crops that are more productive and resistant to drought, identified novel therapeutic targets, and enabled countless other discoveries in epitranscriptomics. </p><p>In this episode: </p>...

  ListenShow Notes
• 

  The Pulse Podcast

  Mark Namchuk: The Art of the Argument Between Science and Business at Every Level

  Mar 27, 202659 minS0

  <p>Mark Namchuk is the Executive Director of Therapeutics Translation at Harvard Medical School. Before he joined Harvard, Mark had a 24-year research and development career in the biotech industry, working in a number of areas, including drug discovery, translational science and pharmaceutical development. Mark began his industry career at Cubist Pharmaceuticals as head of the enzymology group. Then Mark spent 17 years at Vertex, holding a number of senior research positions, including senior vice president of North American research and interim global head of research. In 2015, Mark joined Alkermes as senior vice president. </p><p>In this episode: </p><p>...

  ListenShow Notes
• 

  The Pulse Podcast

  Vicki Sato: Building Modern Biotech Through the Pull and Push

  Mar 20, 20261h 19mS0

  <p>Dr Vicki Sato is a pioneering biotech leader who helped shape the modern biotech industry. She currently serves on the board or in the advisory role for several biotech companies, including Vir Biotechnology, Denali Therapeutics, Allogene Therapeutics, and as a venture partner at ARCH Venture Partners. </p><p>Vicki started her career as an academic scientist. She was a professor in the Department of Cell and Developmental Biology at Harvard. She later made a bold leap into biotech industry, initially joining Biogen and ultimately becoming Chief Scientific Officer and then President of Vertex Pharmaceuticals. At Vertex, she helped drive...

  ListenShow Notes
• 

  The Pulse Podcast

  James Collins: Doing Good Science with an Underdog Spirit

  Mar 8, 20261h 11mS0

  <p>James Collins is the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. Jim serves as a director at the MIT Jameel Clinic, a member of the Harvard-MIT Health Sciences & Technology Faculty, a core founding faculty member of the Wyss Institute, and a member of the Broad Institute. Jim is also an elected member of all three national academies. As one of the founders of synthetic biology, Jim has pioneered research by using synthetic biology and AI to develop next-generation diagnostics and therapeutics, particularly for infectious diseases such as Ebola, Zika, COVID-19 and antibiotic-resistant bacteria...

  ListenShow Notes
• 

  The Pulse Podcast

  Tim Harris: a Journey through 50 years of Biotechnology

  Mar 1, 20261h 14mS0

  <p>Tim Harris is a molecular biologist, biochemist and geneticist. He is also a science and business leader with over 40 years of experience in a range of molecular research areas. Tim is currently an Operating Partner at SV Health Investors. Outside of SV, he holds a seat on the Board of Directors of Phenome TX in Edinburgh and is a visiting professor at Columbia University.</p><p>Before joining SV, Tim served in several senior management positions including Executive VP of Corporate Development at Repertoire Immune Medicines, Executive VP of R&D at Bioverativ (now part of Sanofi-Genzyme), the Senior...

  ListenShow Notes

Recent guests on The Pulse Podcast. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.